Key Performance Metrics
| Metric | Actual 2024 | Target 2024 | % Ach 2024 | Target 2025 |
|---|---|---|---|---|
| Capex | Rp 571 M | Rp 1.2 T | 48% | Rp 900 M |
| Revenue (Growth) | 14.5% | 20-25% | 73% | 10-15% |
| EBITDA (Margin) | 24.3% | 25-30% | 97% | - |
| EBITDA (Growth) | 7.1% | - | - | 15-20% |
| OP Visit | 1,720,492 | - | - | 10-15% |
| IP Days | 133,854 | - | - | 10-15% |
Capital Expenditure (Capex) and Network Expansion
In 2024, PRAY allocated IDR 571 billion in capital expenditure, primarily for medical equipment procurement and new hospital construction. In 2025, Capex is targeted at IDR 900 billion, mainly to support the opening of two greenfield hospitals: Primaya Hospital Kelapa Gading (Q2) and Primaya Hospital BSD (Q4), each starting with 200 beds and built with scalability in mind.
Financial Performance and Growth Outlook
FY2024 saw strong revenue growth achievement at 73% of the target, driven by a surge in patient volume and service expansion. For FY2025, PRAY targets 10–15% revenue growth, supported by both existing and newly opened hospitals, as well as non-hospital business units. EBITDA is expected to grow by 20–25%, driven by pharmacy and medical service cost efficiencies, BPJS optimization strategies, and group-wide operational standardization. A 6–8% pricing adjustment in the private segment will also help sustain margins.
Patient Volume Growth
In 2024, PRAY served more than 1.7 million outpatient visits and recorded 133,854 inpatient days. In 2025, patient volume is projected to grow 10–15% YoY, in line with revenue growth and increased capacity—from 2,017 beds in 2024 to 2,502 beds in 2025.
Specialized Care and Digital Strategy
PRAY continues to strengthen its Centers of Excellence (COEs), including the launch of nuclear medicine services at Kelapa Gading in mid-2025. The company also focuses on digital innovation to enhance operational efficiency and patient experience.
Resilience Amid Regulatory Changes
PRAY is fully prepared for upcoming policy shifts, including the BPJS Kesehatan KRIS regulation effective July 2025. All hospitals have been upgraded to meet KRIS standards, reflecting PRAY’s full support for government healthcare initiatives. Strategic cost controls are also in place to mitigate potential financial pressures from insurance or BPJS changes.
Business Diversification and Medium-Term Plans
Beyond core hospital operations, PRAY is expanding its supporting businesses, including IVF services and its eye care brand, Eye Qu. In 2025, PRAY plans to launch 1–2 new business segments. By 2030, the group aims to operate 25 hospitals with 5,000 beds, shifting towards becoming a tertiary healthcare provider and enhancing its private segment through targeted marketing and specialized services.
